- Hagan H. Hepatitis C virus transmission dynamics in intravenous drug users. Subst Use Misuse 1998; 33: 1197–212.
- Middleton J. Drug misuse in Croatia. Lancet 1994; 344: 604.
- Poljak M, Bednarik J, Rednak K, Seme K, Kristančič L, Čelan-Lucu B. Seroprevalence of human T-cell leukaemia/ lymphoma virus type 1 (HTLV-I) in pregnant women, patients attending venereological outpatients services and intravenous drug users from Slovenia. Folia Biol (Praha) 1998; 44: 23–5.
- Seme K, Poljak M, Jeverica S, Koren A, Žužek-Rešek S. Prevalence of hepatitis G virus infection in Slovenian hemodialysis patients as determined by the detection of viral genome and E2 antibodies. Nephron 1998; 79: 426–9.
- Poljak M, Seme K. Simple one-tube reverse transcription-polymerase chain reaction protocol containing anticontamination procedure for detection of GB virus C/hepatitis G virus RNA. J Virol Methods 1998; 71: 1–6.
- van den Hoek JAR, van Haastrecht HJA, Goudsmit J, de Wolf F, Coutinho RA. Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis 1990; 162: 823–6.
- Rezza G, Sagliocca L, Zaccarelli M, Nespoli M, Siconolfi M, Baldassarre C. Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence. Scand J Infect Dis 1996; 28: 27–9.
- van der Poel CL. Hepatitis C virus. Epidemiology, transmission and prevention. In: Reesink HW, ed. Hepatitis C virus. Basel: Karger, 1994: 137–63.
- Thomas DL, Nakatsuji Y, Shih JW, Alter HJ, Nelson KE, Astemborski JA, et al. Persistence and clinical significance of hepatitis G virus infections in injecting drug users. J Infect Dis 1997; 176: 586–92.
- Stark K, Bienzle U, Hess G, Engel AM, Hegensheid B, Schlüter V. Detection of the hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors. J Infect Dis 1996; 174: 1320–3.
- Schreier E, Höhne M, Künkel U, Berg T, Hopf U. Hepatitis GBV-C sequences in patients infected with HCV contaminated anti-D immunoglobulin and among i.v. drug users in Germany. J Hepatol 1996; 25: 385–9.
- Diamantis I, Bassetti S, Erb P, Ladewig D, Gyr K, Battegay M. High prevalence and coinfection rate of hepatitis G and C infections in intravenous drug addicts. J Hepatol 1997; 26: 794–7.
- Karayiannis P, Pickering J, Chiaramonte M, Thomas HC. Hepatitis G virus infection. Lancet 1997; 349: 954.
- Nübling CM, Bialleck H, Fürsch AJ, Scharrer I, Schramm W, Seifried E, et al. Frequencies of GB virus C/hepatitis G virus genomes and of specific antibodies in German risk and non-risk populations. J Med Virol 1997; 53: 218–4.
Scandinavian Journal of Infectious Diseases
Volume 31, 1999 - Issue 1